why choose us

First received: March 29, 2024

Clinical Trial: Phase 3 Study of Plozasiran in Adults With Hypertriglyceridemia

Study Status: COMPLETED

Recruit Status: COMPLETED

Condition: Hypertriglyceridemia

Study Type: INTERVENTIONAL


Official Title: Double-blind, Placebo-controlled, Phase 3 Study to Evaluate the Efficacy and Safety of Plozasiran in Adults With Hypertriglyceridemia

Brief Summary: This Phase 3 study will evaluate the safety and efficacy of plozasiran injection (ARO-APOC3) in adult participants with hypertriglyceridemia (HTG). After providing informed consent eligible participants will be randomized to receive 4 doses (once every 3 months) of plozasiran or placebo and be evaluated for efficacy and safety.

Read more